{"disease":{"id":"retinitis-pigmentosa","name":"retinitis pigmentosa"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00378742","title":"Repository for Inherited Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":6618,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT00231010","title":"Molecular Genetics of Retinal Degenerations","phase":"","overall_status":"COMPLETED","enrollment_count":3549,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT05589714","title":"Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Jaeb Center for Health Research","has_results":false},{"nct_id":"NCT04620876","title":"Bimodal and Coaxial High Resolution Ophtalmic Imaging","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT04128150","title":"High Resolution Retina Imaging","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT06092346","title":"A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":999,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT01432847","title":"Cell Collection to Study Eye Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":930,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04723160","title":"Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph","phase":"","overall_status":"COMPLETED","enrollment_count":748,"lead_sponsor_name":"Visionary Intelligence Ltd.","has_results":false},{"nct_id":"NCT04141891","title":"Advancing Understanding of Transportation Options","phase":"NA","overall_status":"COMPLETED","enrollment_count":529,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT02617966","title":"Rod and Cone Mediated Function in Retinal Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT00559234","title":"Potential Research Participants for Future Studies of Inherited Eye Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT03584165","title":"Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":330,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT00106743","title":"Natural History and Genetic Studies of Usher Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"National Eye Institute (NEI)","has_results":false},{"nct_id":"NCT04926129","title":"Natural History of the Progression of X-Linked Retinitis Pigmentosa","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT02014389","title":"Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06982417","title":"InsightRP2 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Göttingen","has_results":false},{"nct_id":"NCT07265895","title":"Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03349242","title":"Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":false},{"nct_id":"NCT06388200","title":"A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Ocugen","has_results":false},{"nct_id":"NCT05413148","title":"The Effect of Stem Cells and Stem Cell Exosomes on Visual Functions in Patients With Retinitis Pigmentosa","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":135,"lead_sponsor_name":"TC Erciyes University","has_results":false},{"nct_id":"NCT07056738","title":"Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":130,"lead_sponsor_name":"University Medical Center Goettingen","has_results":false},{"nct_id":"NCT03901391","title":"Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Sensor Technology for Deafblind","has_results":false},{"nct_id":"NCT07082855","title":"A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT05793515","title":"Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Istituto Superiore di Sanità","has_results":false},{"nct_id":"NCT06375239","title":"Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ray Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03975543","title":"Retrospective Natural History Study of Retinitis Pigmentosa","phase":"","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"SparingVision","has_results":false},{"nct_id":"NCT04671433","title":"Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04127006","title":"Rate of Progression in EYS Related Retinal Degeneration","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":103,"lead_sponsor_name":"Jaeb Center for Health Research","has_results":false},{"nct_id":"NCT01680510","title":"The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT05355415","title":"Adaptive Optics Imaging of Outer Retinal Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Food and Drug Administration (FDA)","has_results":false},{"nct_id":"NCT04794101","title":"Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":97,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04448860","title":"Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities","phase":"NA","overall_status":"UNKNOWN","enrollment_count":87,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT06368375","title":"Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"University Hospital Tuebingen","has_results":false},{"nct_id":"NCT04850118","title":"A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Beacon Therapeutics","has_results":false},{"nct_id":"NCT03073733","title":"Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"jCyte, Inc","has_results":true},{"nct_id":"NCT04285398","title":"Prospective Natural History Study of Retinitis Pigmentosa","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":82,"lead_sponsor_name":"SparingVision","has_results":false},{"nct_id":"NCT05800301","title":"Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Ankara Universitesi Teknokent","has_results":false},{"nct_id":"NCT00447980","title":"A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT00447993","title":"A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Neurotech Pharmaceuticals","has_results":true},{"nct_id":"NCT04252534","title":"Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ankara Universitesi Teknokent","has_results":false},{"nct_id":"NCT04909398","title":"Pupil Dynamics and Color Vision for the Detection of Eye Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT04525261","title":"Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Campania Luigi Vanvitelli","has_results":false},{"nct_id":"NCT05809635","title":"Study of BEST1 Vitelliform Macular Dystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":52,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT03116113","title":"A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT05573984","title":"Natural History of PRPF31 Mutation-Associated Retinal Dystrophy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"PYC Therapeutics","has_results":false},{"nct_id":"NCT05258032","title":"Structural and Functional Characterization of Rare Ocular Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Barcelona Macula Foundation","has_results":false},{"nct_id":"NCT07408232","title":"A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Octant, Inc.","has_results":false},{"nct_id":"NCT06076720","title":"Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT03252847","title":"Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":true},{"nct_id":"NCT03057496","title":"Collision Warning Device for Blind and Visually Impaired","phase":"NA","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Massachusetts Eye and Ear Infirmary","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}